Literature DB >> 7204810

Cerebral amyloid angiopathy in the elderly.

M Tomonaga.   

Abstract

In this study an attempt was made to determine the relationship between cerebral amyloid angiopathy (AA) and other cerebrovascular lesions in the aged. The brains of 128 autopsy patients over 60 years of age were examined by both light and electron microscopy. The frequency of cerebral AA increased with age and was 58 percent in patients over the age of 90. The change was observed more often in women than in men. In 7 cases of severe AA, the temporal or occipital cortex was the most common site. Most cases of AA were complicated by the formation of senile plaques in the cortex. Electron microscopic examination revealed amyloid fibrils deposited in clusters in the media and adventitia of the vessels, destroying their structure. Some blood vessels on the surface of the cortex showed hyalinosis, angionecrosis, duplication of the wall, or fibrotic occlusion. AA is sometimes a cause of cerebral bleeding. Five cases of massive cerebral bleeding were found among patients aged 90 or older, including a temporal hematoma in a 92-year-old woman which was believed to be due to the marked AA noted in the temporal lobes. Small cortical infarctions were common in the temporal lobes.

Entities:  

Mesh:

Year:  1981        PMID: 7204810     DOI: 10.1111/j.1532-5415.1981.tb01757.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  27 in total

1.  Amyloid in the brains of aged squirrel monkeys.

Authors:  L C Walker; C Masters; K Beyreuther; D L Price
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

2.  Spinal cord vascular and leptomeningeal amyloid beta-protein deposition in a case with cerebral amyloid angiopathy.

Authors:  T Tokuda; S Ikeda; K Maruyama; N Yanagisawa; N Ito
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

3.  Beta amyloid is focally deposited within the outer basement membrane in the amyloid angiopathy of Alzheimer's disease. An immunoelectron microscopic study.

Authors:  H Yamaguchi; T Yamazaki; C A Lemere; M P Frosch; D J Selkoe
Journal:  Am J Pathol       Date:  1992-07       Impact factor: 4.307

4.  Re-examination of ex-boxers' brains using immunohistochemistry with antibodies to amyloid beta-protein and tau protein.

Authors:  T Tokuda; S Ikeda; N Yanagisawa; Y Ihara; G G Glenner
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

5.  Distribution and morphology of brain stem plaques in Alzheimer's disease.

Authors:  E Iseki; M Matsushita; K Kosaka; H Kondo; T Ishii; N Amano
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

6.  The relationship between cerebral amyloid angiopathy and cortical microinfarcts in brain ageing and Alzheimer's disease.

Authors:  E Kövari; F R Herrmann; P R Hof; C Bouras
Journal:  Neuropathol Appl Neurobiol       Date:  2013-08       Impact factor: 8.090

7.  Microbleeds in the logopenic variant of primary progressive aphasia.

Authors:  Jennifer L Whitwell; Clifford R Jack; Joseph R Duffy; Edythe A Strand; Jeffrey L Gunter; Matthew L Senjem; Matthew C Murphy; Kejal Kantarci; Mary M Machulda; Val J Lowe; Keith A Josephs
Journal:  Alzheimers Dement       Date:  2013-04-03       Impact factor: 21.566

Review 8.  Alzheimer's silent partner: cerebral amyloid angiopathy.

Authors:  Tanya L Cupino; Matthew K Zabel
Journal:  Transl Stroke Res       Date:  2013-11-19       Impact factor: 6.829

9.  Surgical experience with massive lobar haemorrhage caused by cerebral amyloid angiopathy.

Authors:  T Minakawa; S Takeuchi; O Sasaki; T Koizumi; Y Honad; Y Fujii; T Ozawa; H Ogawa; T Koike; R Tanaka
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

Review 10.  Population studies of sporadic cerebral amyloid angiopathy and dementia: a systematic review.

Authors:  Hannah A D Keage; Roxanna O Carare; Robert P Friedland; Paul G Ince; Seth Love; James A Nicoll; Stephen B Wharton; Roy O Weller; Carol Brayne
Journal:  BMC Neurol       Date:  2009-01-13       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.